Medical Progress Today
mpt home | sign up

Volume 4, Number 14
April 20, 2007


PRINTER FRIENDLY

News

Covering the uninsured, but only up to $25,000
Wall Street Journal, 4-18-07

Editor's Notes:

The Journal examines Tennessee's latest effort to insure the low-income uninsured through access to so called "minimedical" plans that offer limited health benefits in return for very low premiums (around $50-$100 per month).
Continue reading . . .

Drug safety bill would limit direct-to-consumer-ads; industry claims free speech violation
Associated Press, 4-17-07

Editor's Notes:

Congress is considering legislation that may sharply limit the ability of pharmaceutical companies to offer direct to consumer advertising on new drugs.
Continue reading . . .

AOL Founder Hopes to Build New Giant Among a Bevy of Health Care Web Sites
The New York Times, 4-16-07

Editor's Notes:

This week, Revolution Health Group, the health care project launched by Steve Case, founder of America Online, debuted its flagship Web site, RevolutionHealth.com.
Continue reading . . .

Commentary

Hospitals Check Their Charts: Rankings Push Them to Improve Care
Steven Pearlstein, Washington Post, 4-20-07

Pearlstein explains why the growing trend toward hospital quality rankings—by both government regulators and private firms—is driving hospital administrators to improve patient care.
Continue reading . . .

Do politicians know better than patients?
Jon Kyl, Real Clear Politics, 4-18-07

Senator Jon Kyl (R, AZ) argues that a recent senate vote on drug price negotiations for the Medicare Part D drug benefit illustrates two very different approaches to health care: one that offers consumers more choices and more control over their health care, and one advocating that bureaucrats should make those choices for them.
Continue reading . . .

Bitter Pills
Wall Street Journal, 4-18-07

The Journal editors explain why they are opposed to ongoing calls for the government to directly negotiate drug prices for the Medicare Part D drug benefit.
Continue reading . . .

Drug Danger
Dr. Scott Gottlieb, Wall Street Journal, 4-17-07

Gottlieb warns that a recent FDA advisory panel vote against approval of a new Cox-2 drug may portend a new stance by the FDA that will limit therapeutic options for patients out of a misguided fear of ever more subtle side effects.
Continue reading . . .

Drugs and Demagogues
Thomas P. Stossel, M.D., The Boston Globe, 4-17-07

Stossel argues that a draft FDA policy that would ban experts with financial ties to drug companies from serving on FDA advisory committees is a short sighted policy that will rob the agency of the best scientific advice.
Continue reading . . .

Drug safety reform at the FDA
New England Journal of Medicine, 4-13-07

McClellan calls for an active drug surveillance system at the FDA that could help rapidly update patients and doctors on emerging safety concerns.
Continue reading . . .

Dr. Santa Comes to Town
Jon Entine, Campaign for Fighting Diseases, 3-26-07

Entine argues that the enormous flood of funds flowing to health projects in poor nations is largely misspent by NGOs that are focused on pleasing their donors rather than building long lasting health care infrastructure.
Continue reading . . .


Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

Universal Health Scare
A four-part debate featuring David Gratzer,
The New Republic Online,
April 16-19, 2007
Day 1: David Gratzer
Day 2: Jonathan Cohn
Day 3: David Gratzer
Day 4: Jonathan Cohn


In this week's issue:

NEWS

Covering the uninsured, but only up to $25,000
Drug safety bill would limit direct-to-consumer-ads; industry claims free speech violation
AOL Founder Hopes to Build New Giant Among a Bevy of Health Care Web Sites

COMMENTARY

Hospitals Check Their Charts: Rankings Push Them to Improve Care
Do politicians know better than patients?
Bitter Pills
Drug Danger
Drugs and Demagogues
Drug safety reform at the FDA
Dr. Santa Comes to Town

COMING SOON!!

New book by Regina Herzlinger: Who Killed Health Care: America's $1.5 Trillion Problem - and the Consumer-Driven Cure (McGraw-Hill, June 2007)

Advanced copies available now at Amazon

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org